The association of platelet-derived endothelial cell growth factor with bladder transitional cell carcinoma

郑一春,丁伟,蔡松良
DOI: https://doi.org/10.3760/j:issn:1000-6702.2003.11.010
2003-01-01
Abstract:Objective To investigate the correlation of clinical and pathological characteristics of bladder transitional cell carcinoma(BTCC) with platelet-derived endothelial cell growth factor (PD-ECGF). Methods Expression of PD-ECGF,VEGF and MVD were examined in the specimens of 52 cases of BTCC by Envision immunohistochemical staining.All the 52 cases were followed up via interview for a period of 5 years. Results Of the 52 cases 50 provided complete relevant data.The 5-year postoperative tumor-free survival rate was 42.9%(21/49) and overall survival rate was 78.0%(39/50).The positive expression rate of PD-ECGF in G 1 tumors was 17.6%(3/17);in G 2,59.3%(16/27) and in G 3,87.5%(7/8)(P 0.01).Tumor-free survival period was (31.87±23.75)months in PD-ECGF positive expression cases,and (42.19±23.84)months in PD-ECGF negative ones (P 0.05).Overall survival period was (48.87± 19.88)months in PD-ECGF positive expression cases, and (57.19±8.97)months in PD-ECGF negative ones (P 0.05). The cases with extremely high MVD had significantly shorter overall survival of (43.50± 22.74)months than the mean of others (high,middle,low MVD) of (56.46±10.98)months,(P0.05).With increase in MVD,the positive expression of VEGF went up obviously,but that of PD-ECGF did not. Conclusions Expression of PD-ECGF and MVD may have significant correlation with biological behavior of BTCC.
What problem does this paper attempt to address?